Detalhe da pesquisa
1.
Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease.
Kidney Int
; 102(2): 261-279, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35513125
2.
Fibroblast growth factor 23 and Klotho contribute to airway inflammation.
Eur Respir J
; 52(1)2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29748308
3.
A Klotho-Derived Peptide as a Possible Novel Drug to Prevent Kidney Fibrosis.
Am J Kidney Dis
; 80(2): 285-288, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35469964
4.
Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats.
Nephrol Dial Transplant
; 32(9): 1493-1503, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28339837
5.
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.
Kidney Int
; 90(5): 985-996, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27457912
6.
Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling.
Elife
; 112022 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35302487
7.
FGF21-FGFR4 signaling in cardiac myocytes promotes concentric cardiac hypertrophy in mouse models of diabetes.
Sci Rep
; 12(1): 7326, 2022 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35513431
8.
FGFR4 does not contribute to progression of chronic kidney disease.
Sci Rep
; 9(1): 14023, 2019 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31575945
9.
Cardioprotective Effects of Paricalcitol Alone and in Combination With FGF23 Receptor Inhibition in Chronic Renal Failure: Experimental and Clinical Studies.
Am J Hypertens
; 32(1): 34-44, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30329020
10.
STAT3-enhancing germline mutations contribute to tumor-extrinsic immune evasion.
J Clin Invest
; 128(5): 1867-1872, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438108
11.
Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice.
J Vis Exp
; (121)2017 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28362385
12.
FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.
Sci Rep
; 7(1): 1993, 2017 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28512310
13.
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.
Cell Metab
; 22(6): 1020-32, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26437603